Head-to-head

Ivim Health vs Direct Meds

Compared on both medications across the eight dimensions this database records. They differ on 6 of those eight. Ivim Health is cheaper on all-in tirzepatide at 10 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.

The short answer

Ivim Health is $353 a month all-in for tirzepatide; Direct Meds is $399. Over twelve months that is $4,236 against $4,788. Value Scores are 46.3 and 45.1 out of 100.

Tirzepatide

Plan pages: Ivim Health plans · Direct Meds plans

At 10 mg/week, Ivim Health is $353 a month all-in and Direct Meds is $399 — $46 apart, or $552 across a year. Over twelve months the totals are $4,236 (billed monthly) and $4,788 (billed monthly).

Ivim Health prices tirzepatide by dose: $208 per month at 2.5 mg rising to $278 at 10 mg, a difference of $70 a month between the bottom and top of the ladder. The company publishes no price at 5, 7.5, 12.5, 15 mg, so those doses are left blank rather than estimated.

Direct Meds prices tirzepatide by dose: $299 per month at 2.5 mg rising to $399 at 10 mg, a difference of $100 a month between the bottom and top of the ladder. The company publishes no price at 5, 7.5, 12.5, 15 mg, so those doses are left blank rather than estimated.

2.557.51012.515mg/week$208$278
Ivim Health in petrol against Direct Meds in graphite — all-in monthly tirzepatide cost at each dose. Second line: Direct Meds.
All-in monthly tirzepatide cost at each published dose, with each program's rank among everyone publishing at that dose
DoseIvim HealthRankDirect MedsRankCheaper
2.5 mg$20810/31$29917/31Ivim Health by $91
5 mgneither publishes
7.5 mgneither publishes
10 mg$2787/27$39920/27Ivim Health by $121
12.5 mgneither publishes
15 mgneither publishes

Ivim Health is cheaper at every dose where both publish a price, so the lead does not change as you titrate.

Across the 27 programs this database can rank on tirzepatide, Ivim Health sits 16 of 27 on all-in monthly cost and Direct Meds sits 22. There are 5 other programs priced between them. The field median is $339 and the floor is $169, so both sit above the median. Ivim Health is $184 above the cheapest tirzepatide program on record. Direct Meds is $230 above the cheapest tirzepatide program on record.

LillyDirect (Zepbound), the lowest FDA-approved tirzepatide channel here, is $449 a month — Ivim Health undercuts it by $96, Direct Meds by $50. Compounded products are not FDA approved; insurance can reverse that comparison.

Published tirzepatide rates per month on each plan term
Plan termIvim HealthDirect MedsCheaper
Month to month$278$399Ivim Health by $121
Twelve months of tirzepatide if you settled at each dose
Settled doseIvim HealthDirect MedsDifference
2.5 mg$3,396$3,588$192 apart
10 mg$4,236$4,788$552 apart

Ivim Health publishes no rate for 3-month term, 6-month term, 12-month term; Direct Meds publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.

A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 10 mg/week, the first twelve months work out to $4,166 on Ivim Health and $4,688 on Direct Meds — $522 apart, and a different gap from the $552 you would get by multiplying the monthly difference by twelve. The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.

That calculation is partial: Ivim Health publishes no price at 2 of the 6 doses and Direct Meds publishes no price at 2 of them, so the maintenance rate stands in for the missing steps rather than a number the company has stated.

Value Scores are 46.3 for Ivim Health and 45.1 for Direct Meds, against a tirzepatide category floor of $169. Ivim Health leads by 1.2 points, driven mostly by price.

Tirzepatide Value Score components
ProgramPrice /70Evidence /15Dose /10Membership /5Total /100
Ivim Health33.512.80046.3
Direct Meds29.610.50545.1

Semaglutide

Plan pages: Ivim Health plans · Direct Meds plans

At 2.4 mg/week, Ivim Health is $224 a month all-in and Direct Meds is $297 — $73 apart, or $876 across a year. Over twelve months the totals are $2,688 (billed monthly) and $3,564 (billed monthly).

Ivim Health charges a flat $149 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay. The company publishes no price at 0.5, 1, 1.7 mg, so those doses are left blank rather than estimated.

Direct Meds prices semaglutide by dose: $249 per month at 0.25 mg rising to $297 at 2.4 mg, a difference of $48 a month between the bottom and top of the ladder. The company publishes no price at 0.5, 1, 1.7 mg, so those doses are left blank rather than estimated.

0.250.511.72.4mg/week$149$149
Ivim Health in petrol against Direct Meds in graphite — all-in monthly semaglutide cost at each dose. Second line: Direct Meds.

Ivim Health is cheaper at every dose where both publish a price, so the lead does not change as you titrate.

Value Scores are 53.1 for Ivim Health and 45.9 for Direct Meds, against a semaglutide category floor of $129. Ivim Health leads by 7.2 points, driven mostly by price.

Where the two programs differ

All-in monthly

Ivim Health is cheaper month to month — $353 against $399, a gap of $46 every month, or $552 across a year if both rates hold.

Cancellation terms

Cancellation differs: Ivim Health states Cancel anytime, while Direct Meds states Per provider terms. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.

Commitment

Ivim Health asks for Month-to-month; Direct Meds asks for Monthly (no commitment indicated). This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.

Evidence status

The two prices are not equally well evidenced. Ivim Health's figure is provider-stated and Direct Meds's is reported. Ivim Health rests on the stronger of the two, and the Value Score below reflects that — evidence quality is worth fifteen points and is not a tiebreaker we apply after the fact.

Membership fee

Ivim Health charges a membership of $75 a month on top of the medication. That is already folded into the all-in figures above — it is broken out here because a membership is a recurring charge that continues even in a month you skip a shipment.

Twelve-month cost

Over twelve months the totals are $4,236 for Ivim Health and $4,788 for Direct Meds. Ivim Health is lower by $552 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.

Dose policy

Both price by dose, so both advertised figures understate the cost of a titration year. Compare the ladders above rather than the headline rates.

Shipping

Shipping is handled the same way by both — included in the quoted price.

What each record says

Ivim Health Official site

Ivim combines a $75/month membership with tiered medication pricing; its all-in semaglutide figure ($149) is competitive, while tirzepatide lands mid-pack at $278 all-in at the 10 mg basis.

It does not publicly name its compounding pharmacy; the record shows Partner pharmacies, so who actually makes the medication cannot be independently verified; commitment terms are Month-to-month; cancellation is Cancel anytime; availability is stated as ~50 states.

Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — ivimhealth.com pricing captures 2026-08-05

Watch: Dose-tiered tirzepatide means the advertised start price understates maintenance cost; compare on the maintenance column.

Direct Meds Official site

Direct Meds offers compounded GLP-1s in multiple formats — sublingual and injectable — with all-inclusive pricing verified on its own product pages. Semaglutide runs $249–$297/mo and tirzepatide $299–$399/mo depending on format; the lower figures are for sublingual delivery.

It does not publicly name its compounding pharmacy; the record shows Partner 503A pharmacy (not publicly named), so who actually makes the medication cannot be independently verified; commitment terms are Monthly (no commitment indicated); cancellation is Per provider terms; availability is stated as Confirm at intake.

Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — rangeyourself.com, Direct Meds product pages verified 2026-07-25

Watch: Pricing varies by format and page; product-page 'all-inclusive' rates differ from homepage promo cards. Rank is based on injectable rate as primary. Reported status — RangeYourself verified 2026-07-25 on Direct Meds' own product pages.

What neither record tells you

Ivim Health does not publish

  • no tirzepatide price at 5, 7.5, 12.5, 15 mg per week
  • no published twelve-month tirzepatide rate
  • no semaglutide price at 0.5, 1, 1.7 mg per week
  • no published twelve-month semaglutide rate
  • no named compounding pharmacy
  • no state-by-state availability list — it says ~50 states

Direct Meds does not publish

  • no tirzepatide price at 5, 7.5, 12.5, 15 mg per week
  • no published twelve-month tirzepatide rate
  • no semaglutide price at 0.5, 1, 1.7 mg per week
  • no published twelve-month semaglutide rate
  • no named compounding pharmacy
  • no state-by-state availability list — it says Confirm at intake
  • no specific cancellation or refund terms

Ask Ivim Health and Direct Meds for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.

What would change this answer

Evidence may be upgraded. Direct Meds carries a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.

Which one suits which reader

On the lowest standing monthly rate for tirzepatide, Ivim Health Official site wins this matchup. If you want to be able to pause without still paying, direct meds carries no membership; and if you would rather trust a better-evidenced number, ivim health's price rests on stronger provenance.

Both figures should be checked at the provider's own checkout before you pay. Ivim Health's tirzepatide price is provider-stated as of 2026-08-05; Direct Meds's is reported as of 2026-07-25.

Questions

Is Ivim Health or Direct Meds cheaper for tirzepatide?

Ivim Health is cheaper on all-in monthly cost at 10 mg/week: $353 against $399, a difference of $46 a month. All-in means the medication plus every mandatory recurring fee.

What is the twelve-month cost of Ivim Health versus Direct Meds?

Ivim Health works out to $4,236 across twelve months and Direct Meds to $4,788, on the plan terms each publishes.

Does Ivim Health or Direct Meds raise the price as the dose goes up?

Ivim Health: yes, it prices by dose. Direct Meds: yes, it prices by dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.

How many ways do Ivim Health and Direct Meds differ?

6 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.

Which of Ivim Health and Direct Meds names its pharmacy?

Neither. Ivim Health records Partner pharmacies and Direct Meds records Partner 503A pharmacy (not publicly named). Without a named pharmacy, neither program's licensing or inspection history can be checked before you order.

How well evidenced are the Ivim Health and Direct Meds prices?

Ivim Health's tirzepatide figure is provider-stated — taken from the provider's own published pages; checkout capture pending — captured 2026-08-05. Direct Meds's is reported, captured 2026-07-25. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.

Which is cheaper for semaglutide?

Ivim Health, at $224 a month all-in against $297 at 2.4 mg/week. The two programs do not necessarily lead on both medications.

Official sources: Ivim Health official site · Direct Meds official site. Compounded tirzepatide and semaglutide are not FDA-approved products.